Cargando…
SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people
The value of SARS-CoV-2 lateral flow immunoassay (LFIA) tests for estimating individual disease risk is unclear. The REACT-2 study in England, UK, obtained self-administered SARS-CoV-2 LFIA test results from 361,801 adults in January-May 2021. Here, we link to routine data on subsequent hospitalisat...
Autores principales: | Whitaker, Matthew, Davies, Bethan, Atchison, Christina, Barclay, Wendy, Ashby, Deborah, Darzi, Ara, Riley, Steven, Cooke, Graham, Donnelly, Christl A., Chadeau-Hyam, Marc, Elliott, Paul, Ward, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432566/ https://www.ncbi.nlm.nih.gov/pubmed/37587102 http://dx.doi.org/10.1038/s41467-023-40643-w |
Ejemplares similares
-
Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England
por: Eales, Oliver, et al.
Publicado: (2023) -
Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people: a large community cross-sectional study in England
por: Atchison, Christina J, et al.
Publicado: (2023) -
REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol
por: Riley, Steven, et al.
Publicado: (2021) -
Persistent COVID-19 symptoms in a community study of 606,434 people in England
por: Whitaker, Matthew, et al.
Publicado: (2022) -
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
por: Ward, Helen, et al.
Publicado: (2021)